|
1
|
Lim JS and Soo RA: Nivolumab in the
treatment of metastatic squamous non-small cell lung cancer: A
review of the evidence. Ther Adv Respir Dis. 10:444–454. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shi JG, Shao HJ, Jiang FE and Huang YD:
Role of radiation therapy in lung cancer management-a review. Eur
Rev Med Pharmacol Sci. 20:3217–3222. 2016.PubMed/NCBI
|
|
3
|
Condoluci A, Mazzara C, Zoccoli A, Pezzuto
A and Tonini G: Impact of smoking on lung cancer treatment
effectiveness: A review. Future Oncol. 12:2149–2161. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang CL, Yokomise H and Miyatake A:
Clinical significance of the p53 pathway and associated gene
therapy in non-small cell lung cancers. Future Oncol. 3:83–93.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bikkavilli RK, Avasarala S, Van Scoyk M,
Arcaroli J, Brzezinski C, Zhang W, Edwards MG, Rathinam MK, Zhou T,
Tauler J, et al: Wnt7a is a novel inducer of β-catenin-independent
tumor-suppressive cellular senescence in lung cancer. Oncogene.
34:5317–5328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vincenten JP, Smit EF, Grünberg K, Postmus
PE, Snijders PJ, Witte BI, Heideman DA and Thunnissen E: Is the
current diagnostic algorithm reliable for selecting cases for EGFR-
and KRAS-mutation analysis in lung cancer? Lung Cancer. 89:19–26.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li B, Lu Y, Wang H, Han X, Mao J, Li J, Yu
L, Wang B, Fan S, Yu X and Song B: miR-221/222 enhance the
tumorigenicity of human breast cancer stem cells via modulation of
PTEN/Akt pathway. Biomed Pharmacother. 79:93–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun L, Burnett J, Gasparyan M, Xu F, Jiang
H, Lin CC, Myers I, Korkaya H, Liu Y, Connarn J, et al: Novel
cancer stem cell targets during epithelial to mesenchymal
transition in PTEN-deficient trastuzumab-resistant breast cancer.
Oncotarget. 7:51408–51422. 2016.PubMed/NCBI
|
|
10
|
Gu J, Wang D, Zhang J, Zhu Y, Li Y, Chen
H, Shi M, Wang X, Shen B, Deng X, et al: GFRα2 prompts cell growth
and chemoresistance through down-regulating tumor suppressor gene
PTEN via Mir-17-5p in pancreatic cancer. Cancer Lett. 380:434–441.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ping Hai P, Bo Feng T, Li L, Hui Nan Y and
Hong Z: IL-1β/NF-kb signaling promotes colorectal cancer cell
growth through miR-181a/PTEN axis. Arch Biochem Biophys. 604:20–26.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu QX, Yuan SX, Ren CM, Yu Y, Sun WJ, He
BC and Wu K: Oridonin upregulates PTEN through activating p38 MAPK
and inhibits proliferation in human colon cancer cells. Oncol Rep.
35:3341–3348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li MF, Guan H and Zhang DD: Effect of
overexpression of PTEN on apoptosis of liver cancer cells. Genet
Mol Res. 15:2016.
|
|
14
|
Lotan TL, Wei W, Ludkovski O, Morais CL,
Guedes LB, Jamaspishvili T, Lopez K, Hawley ST, Feng Z, Fazli L, et
al: Analytic validation of a clinical-grade PTEN
immunohistochemistry assay in prostate cancer by comparison with
PTEN FISH. Mod Pathol. 29:904–914. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xin R, Bai F, Feng Y, Jiu M, Liu X, Bai F,
Nie Y and Fan D: MicroRNA-214 promotes peritoneal metastasis
through regulating PTEN negatively in gastric cancer. Clin Res
Hepatol Gastroenterol. 40:748–754. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu DY, Li XN, Qi Y, Liu DL, Yang Y, Zhao
J, Zhang CY, Wu K and Zhao S: MiR-454 promotes the progression of
human non-small cell lung cancer and directly targets PTEN. Biomed
Pharmacother. 81:79–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mukherjee A and Karmakar P: Attenuation of
PTEN perturbs genomic stability via activation of Akt and
down-regulation of Rad51 in human embryonic kidney cells. Mol
Carcinog. 52:611–618. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bohn BA, Mina S, Krohn A, Simon R, Kluth
M, Harasimowicz S, Quaas A, Bockhorn M, Izbicki JR, Sauter G, et
al: Altered PTEN function caused by deletion or gene disruption is
associated with poor prognosis in rectal but not in colon cancer.
Hum Pathol. 44:1524–1533. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng Z, Zhang Y, Zhang Z, Yang Y and Song
T: Effect of miR-106b on invasiveness of pituitary adenoma via
PTEN-PI3K/AKT. Med Sci Monit. 23:1277–1285. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lim HJ, Wang X, Crowe P, Goldstein D and
Yang JL: Targeting the PI3K/PTEN/AKT/mTOR pathway in treatment of
sarcoma cell lines. Anticancer Res. 36:5765–5771. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu XX, Cao LY, Chen X, Xiao J, Zou Y and
Chen Q: PTEN inhibits cell proliferation, promotes cell apoptosis,
and induces cell cycle arrest via downregulating the PI3K/AKT/hTERT
pathway in lung adenocarcinoma A549 cells. Biomed Res Int.
2016:24768422016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jonason JH, Gavrilova N, Wu M, Zhang H and
Sun H: Regulation of SCF(SKP2) ubiquitin E3 ligase assembly and
p27(KIP1) proteolysis by the PTEN pathway and cyclin D1. Cell
Cycle. 6:951–961. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mamillapalli R, Gavrilova N, Mihaylova VT,
Tsvetkov LM, Wu H, Zhang H and Sun H: PTEN regulates the
ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1)
through the ubiquitin E3 ligase SCF(SKP2). Curr Biol. 11:263–267.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Giannopoulou E, Nikolakopoulos A,
Kotsirilou D, Lampropoulou A, Raftopoulou S, Papadimitriou E,
Theocharis AD, Makatsoris T, Fasseas K and Kalofonos HP: Epidermal
growth factor receptor status and Notch inhibition in non-small
cell lung cancer cells. J Biomed Sci. 22:982015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vesel M, Rapp J, Feller D, Kiss E, Jaromi
L, Meggyes M, Miskei G, Duga B, Smuk G, Laszlo T, et al: ABCB1 and
ABCG2 drug transporters are differentially expressed in non-small
cell lung cancers (NSCLC) and expression is modified by cisplatin
treatment via altered Wnt signaling. Respir Res. 18:522017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Van Nostrand JL, Brisac A, Mello SS,
Jacobs SB, Luong R and Attardi LD: The p53 target gene SIVA enables
non-small cell lung cancer development. Cancer Discov. 5:622–635.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deben C, Wouters A, de Beeck Op K, van Den
Bossche J, Jacobs J, Zwaenepoel K, Peeters M, Van Meerbeeck J,
Lardon F, Rolfo C, et al: The MDM2-inhibitor Nutlin-3 synergizes
with cisplatin to induce p53 dependent tumor cell apoptosis in
non-small cell lung cancer. Oncotarget. 6:22666–22679. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu ZX, Song TB, Li DM, Zhang XT and Wu XL:
Overexpression of PTEN suppresses growth and induces apoptosis by
inhibiting the expression of survivin in bladder cancer cells.
Tumour Biol. 28:9–15. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li X, Lin G, Wu B, Zhou X and Zhou K:
Overexpression of PTEN induces cell growth arrest and apoptosis in
human breast cancer ZR-75-1 cells. Acta Biochim Biophys Sin
(Shanghai). 39:745–750. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan X, Fraser M, Qiu Q and Tsang BK:
Over-expression of PTEN sensitizes human ovarian cancer cells to
cisplatin-induced apoptosis in a p53-dependent manner. Gynecol
Oncol. 102:348–355. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Terra LF, Garay-Malpartida MH, Wailemann
RA, Sogayar MC and Labriola L: Recombinant human prolactin promotes
human beta cell survival via inhibition of extrinsic and intrinsic
apoptosis pathways. Diabetologia. 54:1388–1397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Y, Zeng F, Liu X, Li Y, Zhou J,
Huang Y, Wang Y, Zhou S, Zhu W, Shu E, et al: Chan-Yu-Bao-Yuan-Tang
induces apoptosis in NSCLC and SCLC cell lines via a
mitochondria-mediated pathway. Xenobiotica. 41:593–602. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim MJ, Kwon SB, Kim MS, Jin SW, Ryu HW,
Oh SR and Yoon DY: Trifolin induces apoptosis via extrinsic and
intrinsic pathways in the NCI-H460 human non-small cell lung-cancer
cell line. Phytomedicine. 23:998–1004. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Elankumaran S, Rockemann D and Samal SK:
Newcastle disease virus exerts oncolysis by both intrinsic and
extrinsic caspase-dependent pathways of cell death. J Virol.
80:7522–7534. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yin J, Wang M, Jin C and Qi Q: miR-101
sensitizes A549 NSCLC cell line to CDDP by activating caspase
3-dependent apoptosis. Oncol Lett. 7:461–465. 2014. View Article : Google Scholar : PubMed/NCBI
|
